Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The New England Journal of Medicine|July 30, 2015
Antisense Inhibition of Apolipoprotein C-III in Patients with HypertriglyceridemiaDaniel Gaudet, Veronica J Alexander, Brenda F Baker, et al.
Allergy|November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedemaRemy S Petersen, Laura Bordone, Marc A Riedl, et al.
Journal of Lipid Research|May 17, 2019
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearanceBastian Ramms, Sohan Patel, Chelsea Nora, et al.
The New England Journal of Medicine|March 16, 2022
Inhibition of Prekallikrein for Hereditary AngioedemaLauré M Fijen, Marc A Riedl, Laura Bordone, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
The New England Journal of Medicine|August 8, 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia SyndromeJoseph L Witztum, Daniel Gaudet, Steven D Freedman, et al.
European Heart Journal|January 13, 2022
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular riskJean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, et al.
Circulation|March 30, 2026
Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging StudyNicholas A Marston, Brian A Bergmark, Thomas A Prohaska, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Pageof 4